Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.85

$0 (0.00%)

At close: Sep 22, 2026, 4:00 PM ET

$10.85

$0 (0.00%)

After-hours: Sep 22, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Sep 2, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $263.4M

1D Range

10.82 10.85

52W Range

10.26 10.86

Valuation (TTM)

PE 54.25

PB 1.91

EV/EBITDA -100.38

Valuation (NTM)

Forward PE N/A

Forward PEG -0.55

Price Target N/A

Cash Flow

FCF Yield -0.1%

SBC Adj. FCF Yield -0.1%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA 4.2%

ROE 2.9%

ROIC -1.8%

Financial Health

Net Debt

$929.72K

Current Ratio 0.02

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or oth...

Sector Financial Services

Industry Shell Companies

Employees 2

IPO Date Jan 26, 2025

Website dmaacorp.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.